Horizant ER 600 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZVU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,046
Award facts
- Contract value 100% obligated
- $16,046.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $16,046.28 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 26, 2026, for the supply of Horizant ER 600 mg tablets (30-count units). The contract is non-set-aside and competitively awarded, with performance to be completed by January 27, 2026, at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under Amerisourcebergen Drug Corp's larger relationship with DLA Troop Support Medical, specifically the Pharmaceutical Prime Vendor Global Program, which provides a comprehensive supply vehicle for pharmaceutical and medical commodities supporting military healthcare systems worldwide.
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor serving critical federal medical procurement needs. The company holds a significant $999.9 billion Indefinite Delivery Contract with DLA Troop Support Medical extending through December 2026, enabling supply of a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Amerisourcebergen's consistent success in open competition for DLA medical supply contracts demonstrates its capability to fulfill federal healthcare requirements for military treatment facilities and other government medical institutions.
Quick answers
Who was awarded contract SPE2DR26F4ZVU?
SPE2DR26F4ZVU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F4ZVU worth?
The government has obligated $16,046 on SPE2DR26F4ZVU.
Is contract SPE2DR26F4ZVU an order under another contract?
Yes. SPE2DR26F4ZVU is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZVU competed?
The extent of competition for SPE2DR26F4ZVU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award